Cowan Elvia
SVP, Finance & CAO
Cowan Elvia has filed 10 SEC Form 4 filings (26 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Sep 9, 2026.
On the most recent filing, Cowan Elvia is listed as SVP, Finance & CAO at Vaxcyte, Inc. Inside the rolling window, Cowan Elvia reported no open-market purchases and 4 open-market sales totaling $989K in PCVX. The largest disclosed transaction in the window is a sale of 11,623 PCVX shares on Dec 23, 2025, worth $557K.
Companies traded
Other insiders at PCVX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$989K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Cowan Elvia made?
Cowan Elvia has filed 10 SEC Form 4 filings (26 transaction rows) across 1 company since 2025.
Which companies does Cowan Elvia trade?
Cowan Elvia has filed SEC Form 4 disclosures for 1 company, including PCVX.
When was Cowan Elvia's most recent SEC Form 4 filing?
Cowan Elvia's most recent SEC Form 4 filing on Tracefour is dated Sep 9, 2026.
What is Cowan Elvia's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Cowan Elvia is listed as SVP, Finance & CAO.
What is Cowan Elvia's total buy and sell value in the current window?
Inside the rolling retention window, Cowan Elvia bought $0 and sold $989K based on SEC Form 4 filings.
What was Cowan Elvia's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 11,623 PCVX shares on 2025-12-23, worth $557K, per SEC Form 4 filings.